United Kingdom

Trovagene Inc updates on clinical trial for PCM-075

Monday, 13 Nov 2017 

Nov 13 (Reuters) - Trovagene Inc ::Trovagene announces activation of first clinical trial site in phase 1B/2 acute myeloid leukemia (AML) trial for PCM-075.Trovagene Inc - ‍activation of its clinical trial site for its phase 1B/2 multicenter trial of PCM-075 in patients with AML​.Trovagene Inc - ‍trial will enroll subjects in phase 1B who have relapsed or have resistant disease to no more than three prior regimens​.